The injection of RBA into RA joints blocks the ERK/HIF-1α/GLUT1 signaling pathway, promotes phenotype transformation of macrophages, inhibits inflammatory cytokines and enhances tissue repair. The gene discussed is HIF1A; the disease is rheumatoid arthritis.